<DOC>
	<DOCNO>NCT02841241</DOCNO>
	<brief_summary>This prospective , single arm , `` roll-in '' study esmolol infusion patient septic shock persistent tachycardia adequate intravenous volume expansion . The study evaluate adequacy efficiency study protocol anticipate , main ECASSS study , separate entry clinicaltrials.gov .</brief_summary>
	<brief_title>Esmolol Infusion Patients With Septic Shock Persistent Tachycardia</brief_title>
	<detailed_description>PRIMARY OBJECTIVE : To evaluate adequacy efficiency study protocol anticipate , randomize , control ECASSS study . The primary clinical outcome organ-failure free day 28 day , multiple secondary outcome , include relevant function compliance study protocol .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Esmolol</mesh_term>
	<criteria>1 . Age ≥ 18 year 2 . Within 48 hour admission ICU septic shock ( sepsis present time admission ) a. Septic shock define consensus criterion . At least two systemic inflammatory response syndrome ( SIRS ) criterion ii . Suspected documented infection iii . Receiving vasopressor treat hypotension least 20 ml/kg intravenous crystalloid volume expansion 3 . Receiving vasopressor central venous catheter 60 minute . 4 . Arterial catheter place expect place imminently . 5 . Heart rate &gt; 90/min receive vasopressor 60 minute . 6 . Adequately volume expand , manifest follow , perform part routine clinical care ( i.e. , study procedure perform signed consent ) . If none measure clinically available , clinical attending must confirm volume expansion adequate . ( After enrollment , final safety check confirm adequacy volume expansion . ) 1 . Central venous pressure ( CVP ) &gt; 15 mm Hg . 2 . Negative PassiveLeg Raise ( PLR ) maneuver ( &lt; 10 % increase cardiac output PLR ) . 3 . No cardiac output response ( &lt; 10 % increase ) rapid infusion ( &lt; 5 min ) 250 ml IV crystalloid , i.e. , grade volume expansion challenge ( GVEC ) . 4 . For patient happen breathe passively positive pressure mechanical ventilator deliver least 8 ml/kg tidal volume normal sinus rhythm , stroke volume variability &lt; 10 % ( patient acknowledge uncommon ; protocol recommend require induction passive breathing ) . 1 . Lack informed consent . 2 . Currently receive extracorporeal membrane oxygenation ( ECMO ) . 3 . Known pregnancy nursing . 4 . Patient prisoner . 5 . Patient hospice ( equivalent comfort care approach ) time enrollment . 6 . Known current atrial fibrillation . 7 . Previously enrol trial . 8 . Known allergy esmolol vehicle 9 . Receipt nodal block agent within three half live 10 . Hemoglobin &lt; 7 gm/dl . 11 . Cardiac arrest within 24 hour . 12 . Pulmonary hypertension ( moderate severe ) , document history prior right heart catheterization current evidence transthoracic echocardiogram ( TTE ) follow 1. mean pulmonary artery pressure ( mPAP ) ≥ 35 mmHg 2. systolic pulmonary artery pressure ( sPAP ) ≥ 60 mmHg 13 . Cardiovascular collapse , manifest inability achieve mean arterial pressure ( MAP ) 65 mmHg vasopressor therapy . 14 . Cardiogenic shock , define follow 1 . Cardiac index ≤ 2 L/min/m2 2 . Ejection fraction ≤ 25 % 3 . ScvO2 ≤ 60 % 4 . Current infusion dose dobutamine , milrinone , dopamine 5 . Current infusion epinephrine clinically diagnose cardiogenic shock 15 . Significant atrioventricular dysfunction 1 . Sick sinus syndrome 2 . PR interval &gt; 200 msec 3 . Current evidence prior history Grade 2 Grade 3 heart block 4 . Pacemaker plan place pacemaker 16 . Pheochromocytoma status asthmaticus 17 . Receiving clonidine , guanfacine , moxonidine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>esmolol</keyword>
	<keyword>adrenergic storm</keyword>
	<keyword>septic shock</keyword>
</DOC>